2021
DOI: 10.1007/s11934-021-01038-w
|View full text |Cite
|
Sign up to set email alerts
|

Primary Renal Synovial Sarcoma and Clinical and Pathological Findings: a Systematic Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
27
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(32 citation statements)
references
References 92 publications
0
27
0
Order By: Relevance
“…Surgery was the treatment of choice, with adjuvant chemotherapy; most frequently ifosfamide-based, combined with doxorubicin or epirubicin (9). The median survival time was 34 months, with a mortality rate of 29% and a recurrence rate of 39.8% (9). In our report, the patient underwent a right open radical nephrectomy with six cycles of docetaxel and gemcitabine as adjuvant chemotherapy.…”
Section: Discussionmentioning
confidence: 74%
See 2 more Smart Citations
“…Surgery was the treatment of choice, with adjuvant chemotherapy; most frequently ifosfamide-based, combined with doxorubicin or epirubicin (9). The median survival time was 34 months, with a mortality rate of 29% and a recurrence rate of 39.8% (9). In our report, the patient underwent a right open radical nephrectomy with six cycles of docetaxel and gemcitabine as adjuvant chemotherapy.…”
Section: Discussionmentioning
confidence: 74%
“…The most recent systemic review included 96 studies with 185 cases of PSS of the kidney and showed that surgery, with adjuvant chemotherapy, was the most common treatment. The ifosfamide-based treatment was most frequently used, combined with doxorubicin or epirubicin (9). In the present case, a man who presented with bleeding PSS of the kidney was successfully treated by open radical nephrectomy followed by a docetaxel/gemcitabine adjuvant chemotherapy.…”
Section: Introductionmentioning
confidence: 84%
See 1 more Smart Citation
“…The patients with primary renal synovial sarcoma usually present with hematuria (46.3%), either alone or in combination with other symptoms like pain (43%) or palpable mass (37%) which results in common misdiagnosis of renal cell cancer. The most common sites of metastasis are lung, liver and bone [8]. There are no definite radiological characteristics which can differentiate renal synovial sarcoma from renal cell cancer preoperatively.…”
Section: Discussionmentioning
confidence: 99%
“…With common consensus surgical extirpation in resectable non metastatic cases is considered the therapy of choice. Few case reports have also described doxorubicin and ifosfamide in the neoadjuvant and adjuvant setting [8]. Chediak et al reported complete resolution of a metastatic renal synovial sarcoma with surgery and doxorubicin and ifosfamide chemotherapy [2].…”
Section: Discussionmentioning
confidence: 99%